Xingqi Pharmaceutical
30057342.480.85% ( +0.36 )
Xingqi Pharmaceutical (300573)
Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the P...
- Open
- 41.50
- High
- 42.69
- Low
- 41.38
- Prev. Close
- 42.12
- Volume
- 81.65K
- Turnover
- 344.76M
- Avg Price
- 42.22
- Bid/Ask Ratio
- --
- Amplitude
- 3.11%
- 52wk High
- 58.07
- Volume Ratio
- 0.78
- Turnover Ratio
- 2.29%
Xingqi Pharmaceutical Analyst Rating
View MoreForecast & Rating
Apr 23, 2024Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 28, 2025 at 05:17 AM
Xingqi Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 599 million yuan, an increase of 105.98%
- Zhitong · Oct 9, 2025 at 03:27 AM
Xingqi Pharmaceutical: SQ-129 vitreous body sustained-release injection has obtained clinical trial approval
- Zhitong · Aug 27, 2025 at 08:29 AM
Xingqi Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 335 million yuan, an increase of 97.75%
- Zhitong · Aug 27, 2025 at 06:03 AM
Xingqi Pharmaceutical: Net profit in the first half of 2025 increased by 97.75% year-on-year, plans to distribute 7 yuan for every 10 shares
- Zhitong · Aug 12, 2025 at 03:41 AM
Xingqi Pharmaceutical: The first subject has been enrolled in the Phase II clinical trial of Voriconazole eye drops
- Zhitong · Jul 24, 2025 at 08:58 PM
Ophthalmology concept experiences a volatile rebound, TMSP hits the limit up
